Request for Covid-19 Impact Assessment of this Report
The United States Topical Recombinant Human Thrombin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Topical Recombinant Human Thrombin market, reaching US$ million by the year 2028. As for the Europe Topical Recombinant Human Thrombin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Topical Recombinant Human Thrombin players cover Baxter, Suzhou Zelgen Biopharmaceuticals, Pfizer, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Recombinant Human Thrombin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2000/Bottle
5000/Bottle
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
Suzhou Zelgen Biopharmaceuticals
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Topical Recombinant Human Thrombin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Topical Recombinant Human Thrombin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Topical Recombinant Human Thrombin by Country/Region, 2017, 2022 & 2028
2.2 Topical Recombinant Human Thrombin Segment by Type
2.2.1 2000/Bottle
2.2.2 5000/Bottle
2.2.3 Others
2.3 Topical Recombinant Human Thrombin Sales by Type
2.3.1 Global Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
2.3.2 Global Topical Recombinant Human Thrombin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Topical Recombinant Human Thrombin Sale Price by Type (2017-2022)
2.4 Topical Recombinant Human Thrombin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Topical Recombinant Human Thrombin Sales by Application
2.5.1 Global Topical Recombinant Human Thrombin Sale Market Share by Application (2017-2022)
2.5.2 Global Topical Recombinant Human Thrombin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Topical Recombinant Human Thrombin Sale Price by Application (2017-2022)
3 Global Topical Recombinant Human Thrombin by Company
3.1 Global Topical Recombinant Human Thrombin Breakdown Data by Company
3.1.1 Global Topical Recombinant Human Thrombin Annual Sales by Company (2020-2022)
3.1.2 Global Topical Recombinant Human Thrombin Sales Market Share by Company (2020-2022)
3.2 Global Topical Recombinant Human Thrombin Annual Revenue by Company (2020-2022)
3.2.1 Global Topical Recombinant Human Thrombin Revenue by Company (2020-2022)
3.2.2 Global Topical Recombinant Human Thrombin Revenue Market Share by Company (2020-2022)
3.3 Global Topical Recombinant Human Thrombin Sale Price by Company
3.4 Key Manufacturers Topical Recombinant Human Thrombin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Topical Recombinant Human Thrombin Product Location Distribution
3.4.2 Players Topical Recombinant Human Thrombin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Topical Recombinant Human Thrombin by Geographic Region
4.1 World Historic Topical Recombinant Human Thrombin Market Size by Geographic Region (2017-2022)
4.1.1 Global Topical Recombinant Human Thrombin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Topical Recombinant Human Thrombin Annual Revenue by Geographic Region
4.2 World Historic Topical Recombinant Human Thrombin Market Size by Country/Region (2017-2022)
4.2.1 Global Topical Recombinant Human Thrombin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Topical Recombinant Human Thrombin Annual Revenue by Country/Region
4.3 Americas Topical Recombinant Human Thrombin Sales Growth
4.4 APAC Topical Recombinant Human Thrombin Sales Growth
4.5 Europe Topical Recombinant Human Thrombin Sales Growth
4.6 Middle East & Africa Topical Recombinant Human Thrombin Sales Growth
5 Americas
5.1 Americas Topical Recombinant Human Thrombin Sales by Country
5.1.1 Americas Topical Recombinant Human Thrombin Sales by Country (2017-2022)
5.1.2 Americas Topical Recombinant Human Thrombin Revenue by Country (2017-2022)
5.2 Americas Topical Recombinant Human Thrombin Sales by Type
5.3 Americas Topical Recombinant Human Thrombin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical Recombinant Human Thrombin Sales by Region
6.1.1 APAC Topical Recombinant Human Thrombin Sales by Region (2017-2022)
6.1.2 APAC Topical Recombinant Human Thrombin Revenue by Region (2017-2022)
6.2 APAC Topical Recombinant Human Thrombin Sales by Type
6.3 APAC Topical Recombinant Human Thrombin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Topical Recombinant Human Thrombin by Country
7.1.1 Europe Topical Recombinant Human Thrombin Sales by Country (2017-2022)
7.1.2 Europe Topical Recombinant Human Thrombin Revenue by Country (2017-2022)
7.2 Europe Topical Recombinant Human Thrombin Sales by Type
7.3 Europe Topical Recombinant Human Thrombin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Topical Recombinant Human Thrombin by Country
8.1.1 Middle East & Africa Topical Recombinant Human Thrombin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Topical Recombinant Human Thrombin Revenue by Country (2017-2022)
8.2 Middle East & Africa Topical Recombinant Human Thrombin Sales by Type
8.3 Middle East & Africa Topical Recombinant Human Thrombin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Topical Recombinant Human Thrombin
10.3 Manufacturing Process Analysis of Topical Recombinant Human Thrombin
10.4 Industry Chain Structure of Topical Recombinant Human Thrombin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Topical Recombinant Human Thrombin Distributors
11.3 Topical Recombinant Human Thrombin Customer
12 World Forecast Review for Topical Recombinant Human Thrombin by Geographic Region
12.1 Global Topical Recombinant Human Thrombin Market Size Forecast by Region
12.1.1 Global Topical Recombinant Human Thrombin Forecast by Region (2023-2028)
12.1.2 Global Topical Recombinant Human Thrombin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Topical Recombinant Human Thrombin Forecast by Type
12.7 Global Topical Recombinant Human Thrombin Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Topical Recombinant Human Thrombin Product Offered
13.1.3 Baxter Topical Recombinant Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Suzhou Zelgen Biopharmaceuticals
13.2.1 Suzhou Zelgen Biopharmaceuticals Company Information
13.2.2 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product Offered
13.2.3 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Suzhou Zelgen Biopharmaceuticals Main Business Overview
13.2.5 Suzhou Zelgen Biopharmaceuticals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Topical Recombinant Human Thrombin Product Offered
13.3.3 Pfizer Topical Recombinant Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Topical Recombinant Human Thrombin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Topical Recombinant Human Thrombin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2000/Bottle
Table 4. Major Players of 5000/Bottle
Table 5. Major Players of Others
Table 6. Global Topical Recombinant Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 7. Global Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
Table 8. Global Topical Recombinant Human Thrombin Revenue by Type (2017-2022) & ($ million)
Table 9. Global Topical Recombinant Human Thrombin Revenue Market Share by Type (2017-2022)
Table 10. Global Topical Recombinant Human Thrombin Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Topical Recombinant Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 12. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
Table 13. Global Topical Recombinant Human Thrombin Revenue by Application (2017-2022)
Table 14. Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2017-2022)
Table 15. Global Topical Recombinant Human Thrombin Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Topical Recombinant Human Thrombin Sales by Company (2020-2022) & (K Units)
Table 17. Global Topical Recombinant Human Thrombin Sales Market Share by Company (2020-2022)
Table 18. Global Topical Recombinant Human Thrombin Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Topical Recombinant Human Thrombin Revenue Market Share by Company (2020-2022)
Table 20. Global Topical Recombinant Human Thrombin Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Topical Recombinant Human Thrombin Producing Area Distribution and Sales Area
Table 22. Players Topical Recombinant Human Thrombin Products Offered
Table 23. Topical Recombinant Human Thrombin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Topical Recombinant Human Thrombin Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Topical Recombinant Human Thrombin Sales Market Share Geographic Region (2017-2022)
Table 28. Global Topical Recombinant Human Thrombin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Topical Recombinant Human Thrombin Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Topical Recombinant Human Thrombin Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Topical Recombinant Human Thrombin Sales Market Share by Country/Region (2017-2022)
Table 32. Global Topical Recombinant Human Thrombin Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Topical Recombinant Human Thrombin Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
Table 35. Americas Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
Table 36. Americas Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
Table 38. Americas Topical Recombinant Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 39. Americas Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
Table 40. Americas Topical Recombinant Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 41. Americas Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
Table 42. APAC Topical Recombinant Human Thrombin Sales by Region (2017-2022) & (K Units)
Table 43. APAC Topical Recombinant Human Thrombin Sales Market Share by Region (2017-2022)
Table 44. APAC Topical Recombinant Human Thrombin Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Topical Recombinant Human Thrombin Revenue Market Share by Region (2017-2022)
Table 46. APAC Topical Recombinant Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 47. APAC Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
Table 48. APAC Topical Recombinant Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 49. APAC Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
Table 50. Europe Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
Table 51. Europe Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
Table 52. Europe Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
Table 54. Europe Topical Recombinant Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 55. Europe Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
Table 56. Europe Topical Recombinant Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 57. Europe Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Topical Recombinant Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Topical Recombinant Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Topical Recombinant Human Thrombin
Table 67. Key Market Challenges & Risks of Topical Recombinant Human Thrombin
Table 68. Key Industry Trends of Topical Recombinant Human Thrombin
Table 69. Topical Recombinant Human Thrombin Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Topical Recombinant Human Thrombin Distributors List
Table 72. Topical Recombinant Human Thrombin Customer List
Table 73. Global Topical Recombinant Human Thrombin Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Topical Recombinant Human Thrombin Sales Market Forecast by Region
Table 75. Global Topical Recombinant Human Thrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Topical Recombinant Human Thrombin Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Topical Recombinant Human Thrombin Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Topical Recombinant Human Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Topical Recombinant Human Thrombin Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Topical Recombinant Human Thrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Topical Recombinant Human Thrombin Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Topical Recombinant Human Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Topical Recombinant Human Thrombin Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Topical Recombinant Human Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Topical Recombinant Human Thrombin Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Topical Recombinant Human Thrombin Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Topical Recombinant Human Thrombin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Topical Recombinant Human Thrombin Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Topical Recombinant Human Thrombin Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Topical Recombinant Human Thrombin Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Topical Recombinant Human Thrombin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Topical Recombinant Human Thrombin Revenue Market Share Forecast by Application (2023-2028)
Table 93. Baxter Basic Information, Topical Recombinant Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Topical Recombinant Human Thrombin Product Offered
Table 95. Baxter Topical Recombinant Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Baxter Main Business
Table 97. Baxter Latest Developments
Table 98. Suzhou Zelgen Biopharmaceuticals Basic Information, Topical Recombinant Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 99. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product Offered
Table 100. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Suzhou Zelgen Biopharmaceuticals Main Business
Table 102. Suzhou Zelgen Biopharmaceuticals Latest Developments
Table 103. Pfizer Basic Information, Topical Recombinant Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Topical Recombinant Human Thrombin Product Offered
Table 105. Pfizer Topical Recombinant Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Topical Recombinant Human Thrombin
Figure 2. Topical Recombinant Human Thrombin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Topical Recombinant Human Thrombin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Topical Recombinant Human Thrombin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Topical Recombinant Human Thrombin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2000/Bottle
Figure 10. Product Picture of 5000/Bottle
Figure 11. Product Picture of Others
Figure 12. Global Topical Recombinant Human Thrombin Sales Market Share by Type in 2021
Figure 13. Global Topical Recombinant Human Thrombin Revenue Market Share by Type (2017-2022)
Figure 14. Topical Recombinant Human Thrombin Consumed in Hospital
Figure 15. Global Topical Recombinant Human Thrombin Market: Hospital (2017-2022) & (K Units)
Figure 16. Topical Recombinant Human Thrombin Consumed in Clinic
Figure 17. Global Topical Recombinant Human Thrombin Market: Clinic (2017-2022) & (K Units)
Figure 18. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
Figure 19. Global Topical Recombinant Human Thrombin Revenue Market Share by Application in 2021
Figure 20. Topical Recombinant Human Thrombin Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Topical Recombinant Human Thrombin Revenue Market Share by Company in 2021
Figure 22. Global Topical Recombinant Human Thrombin Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Topical Recombinant Human Thrombin Revenue Market Share by Geographic Region in 2021
Figure 24. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2017-2022)
Figure 25. Global Topical Recombinant Human Thrombin Revenue Market Share by Country/Region in 2021
Figure 26. Americas Topical Recombinant Human Thrombin Sales 2017-2022 (K Units)
Figure 27. Americas Topical Recombinant Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 28. APAC Topical Recombinant Human Thrombin Sales 2017-2022 (K Units)
Figure 29. APAC Topical Recombinant Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 30. Europe Topical Recombinant Human Thrombin Sales 2017-2022 (K Units)
Figure 31. Europe Topical Recombinant Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Topical Recombinant Human Thrombin Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Topical Recombinant Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 34. Americas Topical Recombinant Human Thrombin Sales Market Share by Country in 2021
Figure 35. Americas Topical Recombinant Human Thrombin Revenue Market Share by Country in 2021
Figure 36. United States Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Topical Recombinant Human Thrombin Sales Market Share by Region in 2021
Figure 41. APAC Topical Recombinant Human Thrombin Revenue Market Share by Regions in 2021
Figure 42. China Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Topical Recombinant Human Thrombin Sales Market Share by Country in 2021
Figure 49. Europe Topical Recombinant Human Thrombin Revenue Market Share by Country in 2021
Figure 50. Germany Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Topical Recombinant Human Thrombin Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Topical Recombinant Human Thrombin Revenue Market Share by Country in 2021
Figure 57. Egypt Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Topical Recombinant Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Topical Recombinant Human Thrombin in 2021
Figure 63. Manufacturing Process Analysis of Topical Recombinant Human Thrombin
Figure 64. Industry Chain Structure of Topical Recombinant Human Thrombin
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...